USE OF MASG-PROTEIN-COUPLED RECEPTOR AGONIST AND ANTAGONIST, AS APOPTOTIC ACTIVITY MODULATOR FOR STUDY, PREVENTION AND TREATMENT OF DISEASE

PROBLEM TO BE SOLVED: To provide pharmaceutical compositions for use in gene therapy of diseases and for treatment of variation in organs caused by aging.SOLUTION: The pharmaceutical compositions for use in gene therapy of diseases and for the treatment of variation in organs caused by aging contain...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	DE CASTRO LEAL MARCELO, SILVA LULA IVANA, SINISTERRA RUBEN DARIO, DE FRANCA LUIZ RENATO, DE OLIVEIRA SAMPAIO WALKYRIE NEYDE, BARROS DE SOUSA FREDERICO, FREZARD FREDERIC JEAN GEORGES, KAPPES BECKER LENICE, VELOSO BRANT PINHEIRO SERGIO, SOUZA DOS SANTOS ROBSON AUGUSTO, DOS REIS ADELINA MARTHA, CAMPAGNOLE-SANTOS MARIA JOSE, FERREIRA ANDERSON JOSE, DE FARIA E SILVA RAPHAEL
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	PROBLEM TO BE SOLVED: To provide pharmaceutical compositions for use in gene therapy of diseases and for treatment of variation in organs caused by aging.SOLUTION: The pharmaceutical compositions for use in gene therapy of diseases and for the treatment of variation in organs caused by aging contains cDNA encoding a peptide sequence corresponding to Angiotensin-(1-7) or its antagonist, A-779.